|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.79(B) |
Last
Volume: |
480,476 |
Avg
Vol: |
694,871 |
52
Week Range: |
$39.75 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2018-05-16 |
4 |
S |
$29.80 |
$267,276 |
D/D |
(8,969) |
147,829 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-05-14 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
587,264 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-05-11 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
597,264 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-05-10 |
4 |
AS |
$30.00 |
$120,000 |
D/D |
(4,000) |
47,676 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-05-10 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
607,264 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-05-07 |
4 |
S |
$28.12 |
$29,189 |
D/D |
(1,038) |
51,676 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-05-07 |
4 |
S |
$28.12 |
$72,156 |
D/D |
(2,566) |
23,052 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2018-05-07 |
4 |
S |
$28.27 |
$59,452 |
D/D |
(2,103) |
123,744 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2018-05-04 |
4 |
S |
$27.88 |
$223,709 |
D/D |
(8,024) |
108,226 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-04-17 |
4 |
AS |
$28.00 |
$112,000 |
D/D |
(4,000) |
52,714 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-04-13 |
4 |
AS |
$27.50 |
$94,270 |
D/D |
(3,428) |
56,714 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-03-22 |
4 |
AS |
$30.03 |
$90,090 |
D/D |
(3,000) |
617,264 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-03-21 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
620,264 |
|
- |
|
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2018-03-21 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
156,798 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2018-03-21 |
4 |
AS |
$30.00 |
$120,000 |
D/D |
(4,000) |
116,250 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2018-03-21 |
4 |
AS |
$30.00 |
$224,340 |
D/D |
(7,478) |
125,847 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2018-03-09 |
4 |
S |
$28.88 |
$202,160 |
D/D |
(7,000) |
91,806 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-02-20 |
4 |
S |
$26.89 |
$203,692 |
D/D |
(7,575) |
60,142 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-02-14 |
4 |
S |
$25.26 |
$126,805 |
D/D |
(5,020) |
25,618 |
|
- |
|
Wrighton Mark S |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
102,722 |
|
- |
|
Davis Robyn C |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
7,134 |
|
- |
|
Zane Ellen M |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
45,750 |
|
- |
|
Woollacott Alfred III |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
85,058 |
|
- |
|
Palepu Krishna G. |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
91,243 |
|
- |
|
Allen A Clinton |
Director |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,565 |
75,563 |
|
- |
|
1054 Records found
|
|
Page 15 of 43 |
|
|